Letters Statins and The BMJ

The debate on statins must stay in the public domain

BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5383 (Published 03 September 2014) Cite this as: BMJ 2014;349:g5383
  1. Jerome Burne, journalist1
  1. 1London W9 1EL, UK
  1. jerome{at}burne.myzen.co.uk

As a medical journalist, I’m concerned about the recommendation of the independent panel considering the retraction of two BMJ papers that the ongoing statin debate “be conducted primarily in medical journals rather than in the lay media.”1

How could this be enforced? Could I be fined or imprisoned for reporting dissenting data? And what about The BMJ’s support for transparency? Debate behind closed …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe